Reboxetine in therapy-resistant enuresis: Results and pathogenetic implications

Scandinavian Journal of Urology and Nephrology

Volumn 40, Issue 1, 2006, Pages 31-34

  Nevéus, Tryggve ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Sweden)

Author keywords

Enuresis; Imipramine; Locus coeruleus; Reboxetine

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; DESMOPRESSIN; REBOXETINE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; ENURESIS; FEMALE; HUMAN; MALE; MONOTHERAPY; MOOD DISORDER; NAUSEA; NOCTURNAL ENURESIS; PRIORITY JOURNAL; SLEEP DISORDER;

ABNORMALITIES; ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; CHILD; COHORT STUDIES; DEAMINO ARGININE VASOPRESSIN; DISABLED CHILDREN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENURESIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMIPRAMINE; MALE; MORPHOLINES; PROBABILITY; PROSPECTIVE STUDIES; QUALITY OF LIFE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 32144462630     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.1080/00365590500407803     Document Type: Article

References (30)

1. Rittig S, Knudsen UB, Nørgaard JP, Pedersen EB, Djurhuus JC. Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. Am J Physiol 1989;256:F664-71.
2. Yeung CK, Chiu HN, Sit FK. Bladder dysfunction in children with refractory monosymptomatic primary nocturnal enuresis. J Urol 1999;162:1049-55.
3. Wolfish NM, Pivik RT, Busby KA. Elevated sleep arousal thresholds in enuretic boys: clinical implications. Acta Paediatr 1997;86:381-4.
4. Von Gontard A, Eiberg H, Hollmann E, Rittig S, Lehmkuhl G. Molecular genetics of nocturnal enuresis: clinical and genetic heterogeneity. Acta Paediatr 1998;87:571-8.
5. Nevéus T, Läckgren G, Tuvemo T, Hetta J, Hjälmås K, Stenberg A. Enuresis - background and treatment. Scand J Urol Nephrol Suppl 2000;202:1-44.
6. Aston-Jones G, Chiang C, Alexinsky T. Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance. Prog Brain Res 1991;88:501-20.
7. Sasa M, Yoshimura N. Locus coeruleus noradrenergic neurons as a micturition center. Microsc Res Tech 1994;29:226-30.
8. Fujiwara J, Kimura S, Tsukayama H, Nakahara S, Haibara S, Fujita M, et al. Evaluation of the autonomic nervous system function in children with primary monosymptomatic nocturnal enuresis-power spectrum analysis of heart rate variability using 24-hour Holter electrocardiograms. Scand J Urol Nephrol 2001;35:350-6.
9. Unalacak M, Aydin M, Ermis B, Ozeren A, Sogut A, Demirel F, et al. Assessment of cardiac autonomic regulation in children with monosymptomatic nocturnal enuresis by analysis of heart rate variability. Tohoku J Exp Med 2004;204:63-9.
10. Ornitz EM, Russell AT, Hanna GL, Gabikian P, Gehricke JG, Song D, et al. Prepulse inhibition of startle and the neurobiology of primary nocturnal enuresis. Biol Psychiatry 1999;45:1455-66.
11. Von Gontard A, Schmelzer D, Seifen S, Pukrop R. Central nervous system involvement in nocturnal enuresis: evidence of general neuromotor delay and specific brainstem dysfunction. J Urol 2001;166:2448-51.
12. Glazener CM, Evans JH, Peto RE. Alarm interventions for nocturnal enuresis in children. Cochrane Database Syst Rev 2005;2:CD002911.
13. Glazener CM, Evans JH. Desmopressin for nocturnal enuresis. Cochrane Database Syst Rev 2002;3:CD002112.
14. Glazener CM, Evans JH. Tricyclic and related drugs for nocturnal enuresis in children. Cochrane Database Syst Rev 2000;2:CD002117.
15. Läckgren G, Hjälmås K, van Gool JD, von Gontard A, de Gennaro M, Lottman H, et al. Nocturnal enuresis: a suggestion for a European treatment strategy. Acta Paediatr 1999;88:1-7.
16. Poussaint FA, Ditman SK. A controlled study of imipramine (Tofranil) in the treatment of childhood enuresis. J Pediatr 1965;67:283-90.
17. Martin IG. Imipramine pamoate in the treatment of childhood enuresis. Am J Dis Child 1971;122:42-7.
18. Gepertz S, Nevéus T. Imipramine for therapy resistant enuresis: a retrospective evaluation. J Urol 2004;171:2607-10.
19. Petersen KE, Andersen OO. Treatment of nocturnal enuresis with imipramine and related preparations. A double blind trial with a placebo. Acta Paediatr Scand 1971;60:244.
20. Biegon A, Rainbow TC. Localization and characterization of (3H) desmethylimipramine binding sites in rat brain by quantitative autoradiography. J Neurosci 1983;3:1069-76.
21. Hunsballe JM, Rittig S, Pedersen EB, Olesen OV, Djurhuus JC. Single dose imipramine reduces nocturnal urine output in patients with nocturnal enuresis and nocturnal polyuria. J Urol 1997;158:830-6.
22. Hunsballe JM, Hansen TK, Rittig S, Nørgaard JP, Pedersen EB, Djurhuus JC. Polyuric and non-polyuric bedwetting - pathogenetic differences in nocturnal enuresis. Scand J Urol Nephrol Suppl 1995;173:77-9.
23. Varley CK. Sudden death of a child treated with imipramine. Case study. J Child Adolesc Psychopharmacol 2000;10:321-5.
24. Dostert P, Strolin Benedetti M, Pogessi I. Review of the pharmacokinetics and metabolism of reboxetine, a selective noradrenaline reuptake inhibitor. Eur Neuropsychopharmacol 1997;7(Suppl 1):S23-35.
25. Mucci M. Reboxetine: a review of antidepressant tolerability. J Psychopharmacol 1997;11(Suppl 4):S33-7.
26. Toren P, Ratner S, Laor N, Lerer-Amisar D, Weizman A. A possible antienuretic effect of reboxetine in children and adolescents with attention deficit/hyperactivity disorder: case series. Neuropsychobiology 2005;51:239-42.
27. Nørgaard JP, van Gool JD, Hjälmås K, Djurhuus JC, Hellström A-L. Standardization and definitions in lower urinary tract dysfunction in children. International Children's Continence Society. Br J Urol 1998;81(Suppl 3):1-16.
28. Riva M, Brunello N, Rovescialli AC, Galimberti R, Carfagna N, Carminati P, et al. Effect of reboxetine, a new antidepressant drug, on the central noradrenergic system: behavioural and biochemical studies. J Drug Rev 1989;1:243-53.
29. Grandoso L, Pineda J, Ugedo L. Comparative study of the effects of desipramine and reboxetine on locus coeruleus neurons in rat brain slices. Neuropharmacology 2004;46:815-23.
30. Schou M, Halldin C, Sovago J, Pike VW, Hall H, Gulyas B, et al. PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain. Synapse 2004;53:57-67.